The Atlasi research group is dedicated to studying stem cell and cancer epigenetics. Specifically, we investigate the interplay between cell signalling and chromatin regulation in stem cells, as well as how these mechanisms are deregulated in cancer, including the development of chemotherapy resistance in tumours. We employ various stem cell models, such as embryonic stem cells and tissue-derived organoids, along with cutting-edge genomics, proteomics, and computational biology approaches. Our goal is to make fundamental discoveries that can ultimately address significant health challenges in society.